NeuClone Employee Directory
Pharmaceutical ManufacturingNew South Wales, Australia2-10 Employees
NeuClone is a small, clinical-stage biopharmaceutical company focused on developing and commercialising biosimilar medicines. Based in Sydney, Australia, it operates within the pharmaceutical manufacturing sector and is led by a team of industry veterans. The company aims to build a deep pipeline of biosimilars that can be produced at scale and offered at prices designed to meet demand in both new and established markets worldwide, with an approach that emphasizes confirming biosimilarity early and throughout development. Its target market encompasses global healthcare systems and patients seeking affordable biosimilar options, with a focus on achieving global registration and broad access. In 2019 the company advanced its ustekinumab biosimilar NeuLara into a Phase I trial. Earlier, NeuClone partnered with Serum Institute to develop ten biosimilars for global registration.
1-888-653-2347 
support@leadiq.com 
